The current valuation score of GRI Bio Inc is 8.67, ranking 71 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.00, which is -21850.00% below the recent high of 0.09 and -317600.00% above the recent low of -1.27.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.